Answers are grounded in this paper and cite their sources.
Observational study evaluates fluvoxamine and metformin effects on fatigue in long COVID, suggesting new treatment options.
Postacute sequelae of SARS-CoV-2, or long COVID, presents a major therapeutic challenge, with fatigue being a prevalent and debilitating symptom.
No takes yet. Share an insight, caveat, or question.
Reis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: